Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
This guide introduces zero based budgeting for beginners, simplifying the process. Learn the steps to gain better control over your finances.
17,157 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
DraftKings is diversifying beyond its core betting business. This article examines what that shift could mean for inv...
A single ETF dramatically refreshed the idea of index investing. This guide explains why the QQQ ETF captured investo...
Meta Platforms stock has moved lower—about 17% over six months. This article breaks down what that decline means, how...
On Mar. 12, a niche tech partnership caused a notable move in the stock market today landscape. Ondas jumped after li...
What could Nvidia stock be worth in two years? This article lays out a grounded forecast based on AI demand, data cen...
A tiny $3.7 million exit can mask broader gains in regional bank stocks. This article breaks down what that signal re...
A luxury tax on second homes could reshape New York City's budget and housing market. This article weighs the potenti...
MP Materials jumped about 30% in a month, signaling growing investor interest in U.S. rare-earth supply. This article...
A major institutional purchase in an international rotation ETF has market watchers buzzing. This article unpacks wha...
Analysts tout gains for an overlooked tech name, but the upside may be clouded by rising costs, competition, and macr...
Xcel Brands faces a pivotal year in 2025 as it leans on licensed partnerships and cost discipline. This guide outline...